|
HISTAC EVT
Contents:
Ranitidine HCI
Indications:
150 mg/300 mg tab Duodenal
ulcer & benign gastric ulcer; prevention of NSAID associated duodenal
ulcers. Treatment of post-op ulcer, Zollinger-Ellison syndrone & oesophageal
reflux disease, & conditions where reduction of gastric secretion & acid
output is desirable.
EVT tab Duodenal & gastric ulcer, Zollinger-Ellison syndrome, treatment adjunct in RA for relief of GI
symptoms associated with NSAIDs, reflux oesophagitis, stress ulcers,
short-bowel (anastomosis) syndrome, prophylaxis of GI haemorrhage from
stress ulceration in seriously ill patients, prophylaxis of recurrent
haemorrhage in patients with bleeding peptic ulcers & before GA in patients
at risk of acid aspiration (Mendelson's syndrome), especially obstetric
patients during labour, hypersecretory states associated with systemic
mastocytosis or basophilic leukemia with hyperhistaminemia.
Dosage:
150 mg/300 mg tab Adult
150 mg bd.
Duodenal ulcer, gastric ulcer,
oesophageal reflux Single bedtime dose of 300 mg. Maintenance:
150 mg at bedtime or for oesophageal reflux disease 150 mg bd or 300 mg at
bedtime for 8-12 week.
Severe oesophagitis 150 mg
qds for up to 12 week.
Zollinger-Ellison syndrome
150 mg tds. Max: 6 g/day.
Chronic episodic dyspepsia
150 mg bd for up to 6 week.
Patients at risk of acid
aspiration syndrome 150 mg 2 hr before induction of general anaesthetic
& also 150 mg the previous evening.
EVT tab
Duodenal/gastric ulcer
150 mg bd for at least 4 week. Maintenance: 150 mg nocte.
Prophylaxis against duodenal
ulceration 150 mg bd during therapy with NSAIDs.
GERD 150 mg bd for max 8
week.
Zollinger-Ellison syndrome
Initially 150 mg bd-tds. max: 6 g daily.
Prophylaxis of GI haemorrhage
from stress ulceration in seriously ill patients, prophylaxis of recurrent
haemorrhage in patients with bleeding peptic ulcers 150 mg bd.
Special Precautions:
Severe cirrhosis severe
renal impairment, hepatic impairment. Pregnancy & lactation.
Adverse Reactions:
Hepatitis with or without
jaundice. Acute pancreatitis. Leucopenia, thrombocytopenia, agranulocytosis,
pancytopenia. Bradycardia & AV block. Headache, dizziness, rare cases of
reversible mental confusion, depression & hallucinations. Rash, arthralgia &
myalgia, gynaecomastia.
Drug Interactions:
Phenytoin, warfarin, theophylline,
nifedipine & alcohol. Antacids, procainamide.
Presentation/Packing:
Tab 150 mg x 10 x 10's. 300 mg x
5 x 10's. EVT effervescent tab (
Coolmint flavour) 150 mg x 10's.
US FDA Preg Cat, : B |